Clinical Trials
25 trialsProTACT
Full-Life Technologies GmbH
DANNIgene
Assistance Publique - Hôpitaux de Paris
Kidney Cancer DNA Registry
Memorial Sloan Kettering Cancer Center
LUTACT
University of California, San Francisco
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer
Memorial Sloan Kettering Cancer Center
Mechanisms of Resistance to PSMA Radioligand Therapy
University of California, San Francisco
ELEPHAS-04
Mayo Clinic
TG-BIL
University Hospital, Clermont-Ferrand
Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)
University of Oklahoma
IMMUNEORGANOID
Gustave Roussy, Cancer Campus, Grand Paris
BRICCS
Mayo Clinic
PSMA-PRED
Centre Jean Perrin
Imaging of Solid Tumors Using 18F-TRX
University of California, San Francisco
PROGRESS
UNC Lineberger Comprehensive Cancer Center
EPIDROP
University Hospital, Montpellier
Ultralow Dose PET Imaging for PSMA Expression
Nuclear Imaging Institute
Early Ageing During Therapy in AYA Cancer Patients
University Medical Center Groningen
IREKI
Institut du Cancer de Montpellier - Val d'Aurelle
Application of a Novel Biomarker Based on Plasma cfDNA Assay in the Early Diagnosis of Prostate Cancer
Shanghai Changzheng Hospital
LUTRAC
Erasmus Medical Center
CHANGE
Hospices Civils de Lyon
SoMuKT
IRCCS San Raffaele
PROMIC
Turku University Hospital
PROLIPSY
University Hospital, Montpellier
ONCOPRO
Hospices Civils de Lyon